AT
Athos Therapeutics, Inc.
SEC filingPharmaceuticals · Torrance, CA
Amount raised$10.3Msold at filing
Total offering$20M$9.7M still open
Investors in the raise40count reported to the SEC
FiledMay 15, 2026first sale Apr 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Carl J. McKinzieDirector
Laurence J. SteinDirector
Joel J. CohenDirector
Anthony J. ZingaleDirector
Dimitrios IliopoulosExecutive Officer, Director
Allan J. PantuckExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.